> Industry
Companies already confirmed their attendance:
– Merck sharp & Dohme
– SCIENAMICS GmbH
– Global Life Science Ventures
– Inveni Capital GmbH
– Ventac Partners GmbH
– Schwarz Biosciences GmbH, UCB-Group
– BayerCropScience AG
– Elara Pharmaceuticals GmbH
– Sanofi-Aventis Deutschland GmbH
– UCB Celltech
– AmVac AG
– Debiopharm SA
– Roche Diagnostics Ltd.
– MorphoSys AG
– Bracco Imaging
– TVM Capital
– Boehringer Ingelheim
– Merck KGaA
– Fresenius Biotech
– myIP
– Vossius & Partner
– College Hill
– Pharmalicensing
– Technology Review
– Science Business
– Pieris AG
– MediGene AG
– Vakzine Projekt Management GmbH
– Novartis Pharma GmbH
– CARBOGEN AMCIS AG
– Rentschler Biotechnologie GmbH
– TMV-Japan Tobacco Pharma
– Affectis Pharmaceuticals AG
– Signium International
– Grünenthal GmbH
– Novaliq GmbH
– Bayer Schering Pharma AG
– Focus-IP
– Creathor Venture Management GmbH
– Fresenius Biotech GmbH
– PGxHealth
– Genzyme Limited
– European ScreeningPort
– Earlybird Venture Capital GmbH & CoKG
– NDA Regulatory Service GmbH
– Encysive GmbH
– IP Bewertungs AG
– Olympus Europa